Quantcast

Latest Actavis Stories

2015-03-02 08:34:44

- Treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Adults - DUBLIN, March 2, 2015 /PRNewswire/-- Actavis plc (NYSE: ACT) today announced that

2015-03-02 08:33:30

DUBLIN, March 2, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it is commencing an offering of senior unsecured notes in multiple tranches in a registered public offering

2015-02-24 16:29:10

DUBLIN, Feb. 24, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S.

2015-02-20 08:26:53

DUBLIN, Feb. 20, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has received final approval from the U.S.

2015-02-18 08:30:44

- Unites Global Brand Portfolio Under Allergan Name - DUBLIN, Feb.

2015-02-18 08:30:25

- 9 mid- to late-stage compounds in development - DUBLIN, Feb.

2015-02-18 08:30:00

- Adjusted EBITDA Increases 80% to $1.5 Billion in Fourth Quarter 2014 - DUBLIN, Feb.

2015-02-13 16:24:54

DUBLIN, Feb.